Through expert presentations, participants will learn about exciting advances in gene therapy for the treatment of neuromuscular diseases, including SMA. Speakers will also explore the critical role newborn screening plays in facilitating pre-symptomatic diagnosis and early treatment of disease, and the implementation of newborn screening in Canada. The session will be followed by an interactive live Question & Answer session with all speakers.
Upon completion of this program, participants will be better able to:
Senior Scientist, Genetics & Genome Biology, SickKids Hospital
Pediatric Neurologist, McGill University Health Centre
Paediatrician, The Children’s Hospital of Eastern Ontario
Chief Executive Officer, Muscular Dystrophy Canada
VP of Research & Public Policy at Muscular Dystrophy Canada